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Abstract—This paper describes a high-performance 
impedance measurement circuit for the application of skin 
impedance measurement in the early detection of skin cancer. 
A CMRR improvement technique has been adopted for OTAs 
to reduce the impact of high frequency common mode 
interference. A modified 3-OTA IA has been proposed to help 
with the impedance measurement. Such systems offer a quick, 
non-invasive and painless procedure, thus having considerable 
advantages over the currently used approach, which is based 
upon the testing of a biopsy sample.  The sensor has been 
implemented in 65nm CMOS technology and post layout 
simulations confirms the theoretical claims we made and 
sensor exhibits sensitivity. Circuit consumes 45uW from 1.5V 
power supply. The circuit occupies 0.01954mm2 silicon area. 
Keywords— Skin cancer detection, non-invasive, CMRR; 
Differential pair, Input impedance, Instrumentation amplifier; 
Sensor, Sensitivity, Resistance. 
I.  INTRODUCTION 
In recent days, skin cancer is seen as one of the most 
hazardous forms of cancer found in humans. Skin cancer is 
found in various types such as Melanoma, Basal and 
squamous cell Carcinoma among which Melanoma is the 
most unpredictable. The detection of melanoma cancer in 
early stage can be very helpful to cure. With increased 
flexibility and complex digital processing capability, 
electronics based cancer detection gained a lot of attention 
in the recent days [1]. In this paper, we proposed an 
impedance measurement circuit for use in the early 
detection of skin cancer based on Instrumentation amplifier 
(IA). Currently used techniques require the need for a 
biopsy, which is both invasive and painful. Additionally, the 
analysis of the sample takes some considerable time.  Of 
course, all these procedures require the time of clinicians to 
perform them. The system proposed here will be based on 
accurate measurement of skin electrical resistance, meaning 
that the clinical diagnostic tests will be both non-invasive 
and painless, and can be performed by a non-clinician. A 
radiometric approach is taken, in that measurements are 
taken of both normal and abnormal skin of a patient, and the 
results compared, hence normalizing out any differences in 
skin types, thereby eliminating the misinterpretation of 
results due to this.  Furthermore, the results of the tests will 
be easy to analyses, providing a rapid diagnosis for the 
patient, thus minimizing the distress for the patient caused 
by waiting for the results.   
To date, several independent researchers have been and 
still are investigating the use of skin impedance 
measurements in various clinical situations. As a discipline, 
it has been of interest of a very long time [2] amongst the 
early research.  Skin resistance has been of interest for some 
time for use as a clinical diagnostic tool for the detection of 
cancer. Weitzen [3] had some very interesting results with 
lung, breast, and prostate cancer patients:  The work was 
based on the underlying principle that the skin resistance of 
specific dermal-visceral (DVZs) zones could reflect the 
pathological states of coinciding internal organs due to the 
pathological condition of internal organs inducing 
electrophysiological changes in these corresponding DVZs.  
Their studies have shown that the accuracy of predictions 
based on this technique was surprisingly high.  Weitzen et 
al., [3] discussed the same technique in the detection of 
breast cancer using Electrical Impedance (Mammography) 
systems.   
We have proposed a modification to the existing 
Instrumentation amplifier to be used as an impedance 
measurement circuit. There are three general approaches to 
implementing instrumentation amplifiers in this type of 
application [4-6]. The first approach involves the use of 
operational amplifiers with resistive feedback, but this gives 
often very low CMRR. The Second approach is the 3-OTA 
instrumentation amplifier which is the probably the most 
well-known approach. In this approach two OTAs are used 
to implement a fully differential buffer, which is followed 
by a single OTA configured as a difference amplifier, in this 
configuration CMRR is dominated by the first stage resistor 
mismatch and 2nd stage OTA CMRR. This approach has a 
significant problem with input and output common voltages 
(they must be very close). The use of Current Feedback 
Instrumentation amplifier solves common mode voltage 
problem but often comes with the gain trade-off. The last 
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approach involves the use of switched capacitor techniques 
to overcome the common mode voltages but needs an on-
chip clock and large filter to suppress the ripple. In this 
paper the 3-OTAs architecture has been chosen because of 
its simplicity and since it doesn’t need any clock. A 
traditional OTA with a simple bias often may offer limited 
usage in this application due to its CMRR limitation at high 
frequency, so a CMRR enhancement technique is exploited 
to improve the sensor sensitivity. 
The rest of the paper has been organized as follows. 
Section-2 describes CMR bandwidth enhancement 
technique and rigorous qualitative and quantitative 
explanation has been given. Section-3 describes the very 
limited properties of skin cell and electrical model of the 
cell. Section-4 describes the proposed technique.    
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Fig. 1. Basic differential pair 
II.     BANDWIDTH ENHANCEMENT TECHNIQUE 
 Fig. 1 Shows a generic source coupled differential pair 
with a resistive load. Often this kind of amplifiers needs to 
amplify weak differential signals that are often accompanied 
by strong common-mode (CM) signals. For example, 
differential signals ranging from 10V to 100 mV with a CM 
voltage ranging from 1.9V to 5V. Amplifying such weak 
signals require an amplifier with an offset below 10uV and a 
CMRR more than 100dB, which is quite challenging.  
Additionally, the bandwidth needs to be wide enough to 
minimize any harmonic distortion to acceptable levels for 
the application.  This is very important in biomedical 
applications where a misrepresentation of the signals 
involved could lead to misdiagnosis [7].  
Amplifier inputs V1 and V2 can be expressed as 
differential and common mode components as given by the 
following equations. 
      
  
 
  and        
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Where Vc is common mode input and Vd is differential 
mode input. Amplifier output can be expressed as 
               (2) 
Where Ac is the common mode gain and Ad is the 
differential mode gain. CMRR can be defined as  
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Where Ad and Ac are frequency dependent and hence 
CMRR also frequency dependent. By applying small signal 
model to the Fig. 1 amplifier Differential mode gain can be 
derived as the follows        
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Where Gm is differential pair small signal trans-conductance 
and   
  is the parallel combination of RL and R0 (transistor 
o/p resistance). ωpd gives differential gain dominate pole 
given by  
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Where CL is the load capacitance at output of the differential 
pair, and Cgd, Cgs are the transistor gate to source and gate to 
drain capacitances. 
Common-mode gain can be defined as  
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From the equation (6) Ac exhibits a pole and a zero. Where 
   is the impedance looking into the tail transistor and CT is 
the capacitance looking into the tail transistor drain. CT 
consists of three capacitances, CS, Cdb3, Cgb3 
                 (7) 
Where CS is the stray capacitance at the common source 
node of the differential pair. Clearly common-mode gain 
zero frequency is very less compared to pole frequency 
because   
    . From equation (3), Zeros of common 
mode gain will be the pole of CMRR, so from the above 
description, the 3dB bandwidth of the CMRR is: 
CMRR= 
 
    
  (8) 
Gain bandwidth product of CMRR is:  
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So, for a specified and practically achievable CMRR, the 
only way to improve the bandwidth is either maximize the 
Gm or decrease CT and maximizing Gm only possible by 
increasing current which is costly in terms of the power 
consumption. Generally high CMRR is required to 
minimize the common mode noise at the output. Common 
mode noise sources like 50Hz power supply noise, 10-
20KHz switching noise originated from switching 
converters could interfere with the weak biomedical input 
signals, so a high CMRR value needs to be maintained up to 
these high frequencies to minimise power supply noise. 
Hence, the signal to noise ratio (SNR) of a bio-medical 
transceiver will be improved by increasing the CMRR 
bandwidth. A technique to decrease tail node capacitance by 
neutralization has been presented here. 
Fig. 2 shows proposed solution [8] to enhance the 
CMRR bandwidth. Additional externally biased transistor 
M4 is incorporated into the circuit to compensate gate to 
drain capacitance of transistor M3 and its drain is connected 
to M3 Source. A change in the drain voltage of M3 gives rise 
to a change IJ in the gate-drain capacitance of M3. A part, IK, 
of IJ is returned to the source circuit M3. Hence at the drain 
of M3, Cgd3 appears to be a substantially. 
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Total capacitance at the drain of M3, which was designated 
CT in Fig. 1, now becomes CT1 
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From equation (11) it is very clear that CMRR bandwidth 
has been extended. Like any positive feedback, this 
technique also can potentially make circuit unstable by 
making the capacitance negative, so care must be taken to 
make sure              is always greater than the 
[  
  
  
]       In this design, we swept IK and simulated the 
CMRR.  Up to certain extent the bandwidth will increase 
because the capacitance will decrease, and beyond this IK 
value the circuit will latch due to the +ve feedback.  It is 
therefore important that the IK value doesn’t latch to the rails 
by avoiding -ve capacitance. Fig. 3 shows the CMRR plot 
for the conventional circuit (fixed bias current source 
differential pair) and the proposed bias. Fig. 3 shows that 
with the conventional bias CMRR, the 3-dB bandwidth is 
11.3KHz, and with the proposed biasing technique it has 
been extended to 27.24KHz, which is more than a 100% 
improvement. 
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Fig. 2. CMRR enhancement technique 
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Fig. 3. CMRR frequency response. 
CMRR is generally very sensitive to the process, voltage, 
and temperature (PVT) variations, because from the 
equation (6) the numerator depends on the load resistance 
RL which is typically made of poly-silicon and typically 
varies by 10%.  The denominator depends on the M3 small 
signal output resistance Ro, which varies more than 25% 
across PVT. Unfortunately, both RL, and Ro vary due to 
different physical effects, hence there will be a maximum 
35% PVT variation in CMRR. Fig. 4 shows the simulated 
low frequency CMRR across PVT corners, and displays 
~32% variation. 
 
Fig. 4. CMRR Variation across PVT corners. 
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III.     SKIN TISSUE MODEL 
Living cell membranes can be considered as 
electrochemical in nature, thus allowing some ions to pass 
through, while others are blocked.  This can be considered 
analogous to a leaky capacitor.  The cell itself, along with its 
environment largely consists of electrolytes which have 
resistive characteristics.   
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Fig. 5. Current flow in Tissue. 
Fig. 5 shows the current flow in the tissue, when electricity 
is passed through the body, two types of impedances that are 
capacitive (reactive) C and resistive R are offered by the 
body, where capacitance arises due to the cellular membrane 
and resistance arises due to the body water (could be 
intracellular or extracellular). Cell membrane consists of a 
layer of nonconductive lipid material sandwiched between 
two layers of conductive protein molecules. The high 
reactive value indicates good health and cell membrane 
integrity. Cell membrane structure makes them behave as a 
capacitor when the alternating current is applied to it. Hence 
impedance of tissue varies with frequency. At high 
frequency, current can flow through both intra and extra 
cellular water which means that it can penetrate the cellular 
membrane while at low-frequency current cannot penetrate 
cellular membrane so it flows only through extracellular 
fluid. Thus, at low frequency, impedance is resistive in 
nature and at high frequency, it has a resistive as well as a 
reactive component [9]. As the cells have a capacitive 
element, DC, and low-frequency AC must pass around the 
cell rather than through it. Conversely, at higher frequencies 
current can pass through the cell itself. Ultimately, this 
means differing types of tissue show a different behavior to 
different frequency bands. This means that a model of tissue 
can be developed using resistive and capacitive elements 
[10] [11] as shown below in Fig. 6. Resistances R1, RE 
represents the Intra and extra Cellular fluid effects 
respectively and CM represents the membrane capacitance. 
The frequency response of the impedance can be expressed 
as (12) and shows its low-frequency value is R1+RE and 
high-frequency value goes down to R1 due to the capacitor 
[12]. It has a pole and zero in the frequency response as 
given in (13). Fig. 7 shows the frequency response of the 
tissue impedance. 
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Fig. 6. Tissue model. 
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Fig. 7. Tissue Frequency Responce. 
Typical values for the RE and CM are 8k and 1500pF. 
The Frequency response of the impedance corresponding to 
any Skin tissue is low pass nature with approximately 
13.26kHz 3dB-bandwidth due to shunt capacitance CM. Any 
change in the Tissue impedance nature at a given frequency 
is the clear symptom of cancer or some decease related to 
the skin. 
In the literature, there hasn’t been any research 
pertaining towards skin cancer. There have been several 
ways to measure the impedance, often people tend to use 
Trans-impedance amplifier (TIA) due to its simple nature, 
requires only a high gain amplifier and biasing circuit, but 
unfortunately it consume smore power and noisy. [4] 
proposed an impedance measurement system, but involves 
lot of Digital Signal processing. In this paper, we explored a 
modified Instrumentations-Amplifier (IA) to measure the 
impedance and proposed a way to quantify the level of skin 
cancer.  
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IV.     PROPOSED IC DESIGN 
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Fig. 8. Proposed IA-based circuit. 
Fig. 8 depicts our proposed impedance measurement 
circuit derived from 3-OTA instrumentation amplifier. 
Generally, instrumentation amplifier requires two voltages 
as inputs and will be converted into a current. Here an 
accurate external low-frequency signal is used to excite the 
circuit through non-inverting input of the op-amp OP2 and 
through Inverting amplifier OP1 complimentary input signal 
–vin has been generated. The voltage across the sensor is 
2Vin, provided the OTA (OP1) offset is very low, and the 
feedback resistors around OP1 match very well. Any offset 
or mismatch in the components will result in errors at the 
output of the inverting amplifier will could lead to a clinical 
misdiagnosis. To minimize the mismatch induced offset, 
OP1 has been designed with larger physical size 
components. Fig. 9 shows the simulated gain of the 
inverting amplifier formed by OP1 with the component 
mismatch (Monte-Carlo Simulation). The histogram shows 
unity gain with 1.9% of standard deviation, which roughly 
indicates that the output will have 1.9% error. A voltage to 
current conversion will occur and current will flow through 
OP2 and OP3 feedback resistors. Node x (OP2 output) 
voltage is depending on the input voltage and current 
through the sensor. Since we are interested only sensor 
current ideally we should subtract input signal voltage from 
node x, so we used summer as a final stage. All node 
voltages and branch currents have been highlighted in in 
Fig. 9. Common mode rejection of the final summer 
amplifier impacts the sensitivity of the sensor, so the current 
CMRR enhancement technique would help a lot here. To 
measure the impedance, change due to cancer attack, few 
parameters of this circuit can be measured as detection 
parameter. The current through the skin cell give very good 
indication because voltage across the skin cell is 2VIN hence 
current depends on the impedance but this current must be 
much lesser than 350uA due to safety limits, otherwise cell 
properties will change. The voltage output voltage of the 
sensor also gives reasonable estimation of the impedance, 
hence cancer level. The sensitivity of the of the circuit can 
be defined as a change in the output voltage per unit sensor 
capacitance for a given input signal. 
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Fig. 9. Inverting Amplifier Gain Histogram.  
A two-stage folded cascode OTA [13] architecture show 
in Fig. 10 has been chosen for its input and output common 
voltage compatibility and High gain. As explained in the 
previous sections, CMRR bandwidth enhancement tech also 
been adopted, so that this sensor can accepted much higher 
frequency of input signal due to the proposed bias technique 
without having any power or performance overhead. To 
achieve closed loop settling error less than 0.1%, the loop-
gain of the any negative feedback loop in the circuit should 
be greater than 60dB across all PVT (process, voltage, 
Temperature) corners. To as to maintain less gain variation 
and minimal input referred offset, self-bias technique has 
been adopted [13]. Fig. 11 shows the loop gain of the 
amplifier with and without self-bias technique, shows 
significant improvement. Since it is a two stage OTA, need 
to compensate for the well behaved transient response 
otherwise it may oscillate or even compromises the 
sensitivity, so miller compensation has been used by placing 
a capacitor (CC) across the second stage. From the stability 
point of view summing amplifier (consists of OP4) is 
difficult one because of the higher feedback ratio. Fig. 12 
shows the frequency response of the closed loop response, 
shows 550 phase margin. Each unit resistor used in the 
design is 1kΩ and Value of N (the resistor ratio shown in 
Fig. 5) is 60. The power supply rejection of the op-amp is 
around -70dB in the frequency of interest such that it will 
not impact sensor accuracy.  
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Fig. 10. OTA architecture used for Sensor design.  
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Fig. 11. Low frequency Loop-Gain across PVT corners 
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Fig. 12. Frequency response of the closed loop 
V. SENSOR RESULTS 
The impedance sensor instrumentation has been 
implemented in 65nm 1P8M CMOS technology and post 
layout simulations have been performed. Tissue probes 
connections are explicitly placed below the amplifiers so 
that it can be integrated without having difficulty in 
assigning power connections. Post-layout simulations have 
been performed on the final layout. We applied a 10mV, 
10KHz sinusoidal excitation for the sensor and Fig. 13 
shows the current through skin cell and voltage at the output 
of the circuit while sweeping the cell model capacitance 
from 1500pF to 3500pF. As explained in section-IV, for a 
given input signal amplitude, the sensor output voltage 
linearly varies with skin tissue capacitance. Over the range 
of tissue capacitance output voltage has been changed by 
47mV hence this sensor has a sensitivity of 23.5uV/pF. The 
sensitivity we have expressed is directly related to the 
capacitance. Higher the sensor output, severe the skin 
cancer attach. 
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Fig. 13. Sensor output voltage vs input capacitance. 
Fig. 14 shows the frequency response of the sensor, 
which depicts sensor output voltage versus frequency of the 
applied signal for a given capacitance. At all frequencies, 
the output voltage increases with capacitance. Results in 
Fig. 13 and Fig. 14 are agreeing with each other’s apart 
from the fact that one is in the time domain and another is in 
the frequency domain. Fig. 15 shows the layout of the 
proposed sensor, it occupies 0.01914mm2 active silicon 
area, most of the area has been occupied by the resistors and 
compensation capacitor. Used typical layout techniques like 
common centroid and inter-digitization of the current 
mirrors to minimize the linear gradient proposes variations. 
Layout. 
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Fig. 14. Frequency response of the sensor. 
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Fig. 15. The layout of the sensor 
VI. CONCLUSION 
We have presented a skin impedance measuring circuit 
that can be used to evaluate and compare the electrical 
properties of normal and abnormal Epidermis, hence 
providing the possibility of the early detection of skin 
cancer. According to the authors knowledge this is the first 
skin sensor CMOS technology IC in the literature. A 2.5 
times improvement in CMRR bandwidth has also been 
demonstrated for the differential amplifier. A sensitivity of 
23.5uV/pF demonstrated. As a future work, need to find a 
way to convert output voltage into digital domain, probably 
by adding ADC, so that it can be very easily integrated to a 
DSP to process the and store the results. The circuit 
occupies an area of 132x145um2 
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